Clinical Trials Directory

A Pilot Study to Assess the Utility of Indocyanine Green? (IC-GREEN?) SPY Imaging in the Mapping of Arm Draining Lymphatics and Nodes During Sentinel Node Resection With or Without Axillary Dissection in Breast Cancer

To determine concordance between isosulfan blue (ISB) and indocyanine green (IC-GREEN?) in the identification of lymphatics and arm-draining nodes during nodal staging procedures in breast cancer.

Stanford is now accepting new patients for this trial.



  • device : (IC-GREEN?) SPY Elite® Imaging

Phase: N/A


Ages Eligible For Study:

18 Years - 90 Years

Inclusion Criteria

- Ability to understand and the willingness to sign a written informed consent document. - Signed written informed consent. - Women undergoing sentinel lymph node biopsy. - Women with breast cancer with known or suspected lymph node involvement. - Women undergoing sentinel node identification and completion axillary lymph node dissection. - Women of 18 years of age or older. - Eastern Cooperative Oncology Group (ECOG) or Karnofsky Performance Status 0,1,2. - Complete Blood Count (CBC) and basic Metabolic Panel within 6 months

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Shannon Meyer

Footer Links: